Form 4: Cytokinetics Executive Sells Shares
Insider Transaction (Form 4)
Fady Ibraham Malik, EVP Research & Development of Cytokinetics Inc, sold 3,500 shares of common stock on September 8, 2026 for $75.46 per share.
Summary
- Option exercise/conversion: acquired 3,500 Common Stock at $7.80 ($27,300) on September 8, 2026; holds 157,402 after (Direct).
- Open-market sale: disposed of 3,500 Common Stock at $75.46 ($264,110) on September 8, 2026; holds 153,902 after (Direct).
- Option exercise/conversion: disposed of 3,500 Non-Qualified Stock Option (Right to Buy) on September 8, 2026; holds 26,886 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $264,110 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Fady Ibraham Malik — Officer (EVP Research & Development)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Option exercise/conversion | Common Stock | 3,500 | $8 | $27.3K | 157,402 |
| 2026-09-08 | Open-market sale | Common Stock | 3,500 | $75 | $264.1K | 153,902 |
| 2026-09-08 | Option exercise/conversion | Non-Qualified Stock Option (Right to Buy) | 3,500 | — | — | 26,886 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Option exercise/conversion (3,500 shares) |
| 2026-09-08 | Open-market sale (3,500 shares) |
| 2026-09-08 | Option exercise/conversion (3,500 shares) |
Keywords
insider transaction, Form 4, CYTK, CYTOKINETICS INC, bearish, Fady Ibraham Malik
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.